Shih-En Tang

705 total citations
33 papers, 508 citations indexed

About

Shih-En Tang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Shih-En Tang has authored 33 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 8 papers in Molecular Biology and 6 papers in Physiology. Recurrent topics in Shih-En Tang's work include Respiratory Support and Mechanisms (8 papers), Neonatal Respiratory Health Research (4 papers) and Cardiac Ischemia and Reperfusion (4 papers). Shih-En Tang is often cited by papers focused on Respiratory Support and Mechanisms (8 papers), Neonatal Respiratory Health Research (4 papers) and Cardiac Ischemia and Reperfusion (4 papers). Shih-En Tang collaborates with scholars based in Taiwan, Japan and United States. Shih-En Tang's co-authors include Kun‐Lun Huang, Shi-Jye Chu, Shuyu Wu, Wen-I Liao, Chung‐Kan Peng, Geng-Chin Wu, Chin‐Pyng Wu, Shu‐Yu Wu, Chou‐Chin Lan and Wann‐Cherng Perng and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Shih-En Tang

32 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shih-En Tang Taiwan 13 165 136 79 74 64 33 508
Carla Moran United Kingdom 22 268 1.6× 123 0.9× 69 0.9× 92 1.2× 73 1.1× 52 1.3k
Ting‐Hua Yang Taiwan 21 222 1.3× 70 0.5× 58 0.7× 130 1.8× 72 1.1× 53 983
Eun Pyo Hong South Korea 13 259 1.6× 92 0.7× 45 0.6× 42 0.6× 45 0.7× 46 850
Gai Liang China 13 164 1.0× 86 0.6× 47 0.6× 104 1.4× 44 0.7× 27 730
Rong Lin China 17 300 1.8× 68 0.5× 66 0.8× 108 1.5× 142 2.2× 74 850
Zheng‐Wei Yang China 15 181 1.1× 42 0.3× 58 0.7× 95 1.3× 70 1.1× 36 682
Feng Zheng China 17 263 1.6× 109 0.8× 155 2.0× 72 1.0× 150 2.3× 49 887
Yicong Chen China 15 139 0.8× 97 0.7× 39 0.5× 39 0.5× 37 0.6× 52 611
Lawrence M. Simon United States 13 121 0.7× 108 0.8× 51 0.6× 97 1.3× 91 1.4× 25 511

Countries citing papers authored by Shih-En Tang

Since Specialization
Citations

This map shows the geographic impact of Shih-En Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shih-En Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shih-En Tang more than expected).

Fields of papers citing papers by Shih-En Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shih-En Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shih-En Tang. The network helps show where Shih-En Tang may publish in the future.

Co-authorship network of co-authors of Shih-En Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Shih-En Tang. A scholar is included among the top collaborators of Shih-En Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shih-En Tang. Shih-En Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Shu‐Yu, et al.. (2024). Monomethyl fumarate attenuates lung Ischemia/Reperfusion injury by disrupting the GAPDH/Siah1 signaling cascade. International Immunopharmacology. 137. 112488–112488. 3 indexed citations
2.
Wu, Shuyu, et al.. (2023). Alda-1 ameliorates air embolism-induced acute lung injury. International Journal of Immunopathology and Pharmacology. 37. 1200443101–1200443101. 2 indexed citations
3.
Liao, Wen-I, et al.. (2023). Targeting Rev-Erbα to protect against ischemia-reperfusion-induced acute lung injury in rats. Respiratory Research. 24(1). 247–247. 3 indexed citations
4.
Chung, Chi‐Hsiang, Yung‐Ho Hsu, Chia‐Chao Wu, et al.. (2023). Risk of secondary stroke subsequent to restarting aspirin in chronic stroke patients suffering from traumatic brain injury in Taiwan. Scientific Reports. 13(1). 8001–8001. 2 indexed citations
5.
Chung, Ren‐Jei, Bing‐Long Wang, Yu‐Ching Chou, et al.. (2022). Adult abuse and poor prognosis in Taiwan, 2000–2015: a cohort study. BMC Public Health. 22(1). 2280–2280. 1 indexed citations
6.
Chu, Shi-Jye, et al.. (2022). A High-Fiber Diet or Dietary Supplementation of Acetate Attenuate Hyperoxia-Induced Acute Lung Injury. Nutrients. 14(24). 5231–5231. 8 indexed citations
7.
Chen, Chu-Chieh, Ren‐Jei Chung, Chi‐Hsiang Chung, et al.. (2022). Obese patients experience more severe OSA than non-obese patients. Medicine. 101(41). e31039–e31039. 4 indexed citations
8.
Tang, Shih-En, et al.. (2022). Man on Noninvasive Positive Airway Pressure Ventilation With Throat Pain.. PubMed. 12(4). 158–160.
9.
Liao, Wen-I, et al.. (2021). Suppression of Endoplasmic Reticulum Stress by 4-PBA Protects Against Hyperoxia-Induced Acute Lung Injury via Up-Regulating Claudin-4 Expression. Frontiers in Immunology. 12. 674316–674316. 56 indexed citations
10.
Tang, Shih-En, Wen-I Liao, Chin‐Wang Hsu, et al.. (2021). Poloxamer 188 Attenuates Ischemia-Reperfusion-Induced Lung Injury by Maintaining Cell Membrane Integrity and Inhibiting Multiple Signaling Pathways. Frontiers in Pharmacology. 12. 650573–650573. 14 indexed citations
11.
Chu, Shi-Jye, et al.. (2021). Protease-Activated Receptor-1 Antagonist Protects Against Lung Ischemia/Reperfusion Injury. Frontiers in Pharmacology. 12. 752507–752507. 12 indexed citations
12.
Peng, Chung‐Kan, Shuyu Wu, Yu Wang, et al.. (2021). Obesity Attenuates Ventilator-Induced Lung Injury by Modulating the STAT3–SOCS3 Pathway. Frontiers in Immunology. 12. 720844–720844. 11 indexed citations
13.
Wang, Sheng‐Huei, Weishan Chen, Shih-En Tang, et al.. (2019). Benzodiazepines Associated With Acute Respiratory Failure in Patients With Obstructive Sleep Apnea. Frontiers in Pharmacology. 9. 1513–1513. 34 indexed citations
14.
Liao, Wen-I, Shuyu Wu, Geng-Chin Wu, et al.. (2017). Ac2-26, an Annexin A1 Peptide, Attenuates Ischemia-Reperfusion-Induced Acute Lung Injury. International Journal of Molecular Sciences. 18(8). 1771–1771. 48 indexed citations
15.
Peng, Chung‐Kan, Shuyu Wu, Shih-En Tang, et al.. (2017). Protective Effects of Neural Crest-Derived Stem Cell-Conditioned Media against Ischemia-Reperfusion-Induced Lung Injury in Rats. Inflammation. 40(5). 1532–1542. 7 indexed citations
16.
Wu, Geng-Chin, Wen-I Liao, Shuyu Wu, et al.. (2017). Targeting of nicotinamide phosphoribosyltransferase enzymatic activity ameliorates lung damage induced by ischemia/reperfusion in rats. Respiratory Research. 18(1). 71–71. 20 indexed citations
17.
Lan, Chou‐Chin, Chung‐Kan Peng, Shih-En Tang, et al.. (2016). Anti-Vascular Endothelial Growth Factor Antibody Suppresses ERK and NF-κB Activation in Ischemia-Reperfusion Lung Injury. PLoS ONE. 11(8). e0159922–e0159922. 20 indexed citations
18.
Tang, Shih-En, et al.. (2016). Tuberculosis-related giant bullae mimicking tension pneumothorax. Internal and Emergency Medicine. 12(7). 1069–1070. 1 indexed citations
19.
Lan, Chou‐Chin, Chung‐Kang Peng, Shih-En Tang, et al.. (2016). Inhibition of Na-K-Cl cotransporter isoform 1 reduces lung injury induced by ischemia–reperfusion. Journal of Thoracic and Cardiovascular Surgery. 153(1). 206–215. 23 indexed citations
20.
Tang, Shih-En, Chin‐Pyng Wu, Shuyu Wu, et al.. (2014). Stanniocalcin-1 ameliorates lipopolysaccharide-induced pulmonary oxidative stress, inflammation, and apoptosis in mice. Free Radical Biology and Medicine. 71. 321–331. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026